RxDoctor Payments Data

Jason Tartaglione, MD

Foot and Ankle Surgery · Warwick, RINPI 1386900165

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (36.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Kairos Surgical Inc at 35.3% of the total. Reporting peaked in 2022 at $5,675 and has fallen 71.4% since, to $1,623 in 2025.

$20,973in general payments, 2019–2025

Across 98 payments — averaging $214.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$7K
  • Stryker$7K
  • Medshape, Inc.$2K
  • Arthrex$2K
  • Trilliant Surgical LLC.$2K
  • Coastal Technology Solutions LLC$648
  • plus $1K from 9 others

What the payments were for

  • Travel & lodging$6,65532%
  • Food & beverage$6,61932%
  • Education$7,69837%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,973 in reported general payments places this provider in the 85th percentile of 58 foot and ankle surgery providers in Rhode Island.

See all foot and ankle surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$191,547
Medicare patients
288
Services billed
9,339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen23$235
Meloxicam55$209
Oxycodone Hcl12$61
Tranexamic Acid11$56
Clindamycin Hcl26$56
Omeprazole12$6

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Warwick

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →